Experts explore the impact of hemophilia on patients’ lives, economic impact, and the crucial role of specialty pharmacists.

Lisa Schrade, PharmD, discusses factor replacement therapies and emicizumab’s role in treating hemophilia.

Robert Sidonio Jr, MD, MSc, discusses patient-centered therapy choices, highlighting the diverse options and considerations for hemophilia A treatment.

Atta Chowdhry, RPh, discusses treatment approaches for acute episodes and prophylaxis in patients with hemophilia A.

Experts discuss best practices for improving patient adherence to hemophilia A therapies, including addressing adherence issues and patient engagement.

Robert Sidonio Jr, MD, MSc, shares insights on monitoring and managing side effects in hemophilia A treatment to ensure patient safety and adherence.

Lisa Schrade, PharmD, and Robert Sidonio Jr, MD, MSc, discuss strategies for identifying and managing adverse effects in outpatient hemophilia A treatment, emphasizing collaboration and patient education.

Atta Chowdhry, RPh, and Robert Sidonio Jr, MD, MSc, discuss the emergence of gene therapy as an exciting option for patients with hemophilia A and highlight benefits, limitations, and ongoing research in the field.

Lisa Schrade, PharmD, explores the implications of real-world data comparing standard half-life and extended half-life products in hemophilia A treatment.

Robert Sidonio Jr, MD, MSc, discusses studies on inhibitor formation in patients with hemophilia A using prophylaxis, addressing the challenges of mitigating inhibitor risk and the impact on treatment strategies.

Experts discuss adherence to emicizumab in real-world settings, comparing it to factor products and highlighting the convenience and ease of administration associated with emicizumab.

Lisa Schrade, PharmD, and Robert Sidonio Jr, MD, MSc, discuss real-world evidence for hemophilia A therapies, highlighting their safety, efficacy, and impact on bleeding events, nurse visits, and hospital visits.

Atta Chowdhry, RPh, and Robert Sidonio Jr, MD, MSc, discuss the safety and efficacy of gene therapy for hemophilia A, highlighting recent approvals, with insights into adverse effects, immunosuppression, and the evolving treatment landscape.

Lisa Schrade, PharmD, and Robert Sidonio Jr, MD, MSc, explore the integral partnership between specialty pharmacists and hematologists in managing patients with hemophilia.

Atta Chowdhry, RPh, and Lisa Schrade, PharmD, discuss best practices in coordinating specialty pharmacy services between payers and prescribers to ensure timely access to critical hemophilia treatments.

Experts discuss the critical role of specialty pharmacists in advocating for patients during challenging moments in their hemophilia treatment journey and explore precision dosing considerations and the importance of adherence to dosing guidelines.

Lisa Schrade, PharmD, and Robert Sidonio Jr, MD, MSc, explore hemophilia A adherence and how specialty pharmacists can empower patients to take control of their healthcare through proactive engagement, personalized routines, and switching strategies when necessary.

A panel of experts explore the evolving role of specialty pharmacists in hemophilia care, including gene therapy, adherence strategies, and the transformative impact on patients' lives.